CODX stock forecast
Our latest prediction for Co-Diagnostics, Inc.'s stock price was made on the May 11, 2018 when the stock price was at 1.84$.
In the short term (2weeks), CODX's stock price should outperform the market by 5.67%. During that period the price should oscillate between -8.97% and +21.35%.
In the medium term (3months), CODX's stock price should outperform the market by 3.40%. During that period the price should oscillate between -21.34% and +51.90%.Get email alerts
About Co-Diagnostics, Inc.
Co-Diagnostics, Inc. is a molecular diagnostics company, which engages in the development, manufacture, and marketing of diagnostics technology. The company's products are utilized for tests that are designed using the detection and analysis of nucleic acid molecules. It also uses its proprietary technology to design tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.46$ per share.
The book value per share is 0.10$
Three months stock forecastMay 11, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|